ClinicalTrials.gov record
Recruiting Phase 3 Interventional

The Cancer of the Pancreas Screening-5 CAPS5)Study

ClinicalTrials.gov ID: NCT02000089

Public ClinicalTrials.gov record NCT02000089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02000089
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Johns Hopkins University
Other
Enrollment
9,000 participants

Conditions and interventions

Interventions

  • MRI Diagnostic Test
  • Secretin Drug
  • Tumor marker gene test with CA19-9 Other

Diagnostic Test · Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2014
Primary completion
Nov 30, 2028
Completion
May 31, 2029
Last update posted
Oct 8, 2025

2014 – 2029

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Yale University New Haven Connecticut 06520 Recruiting
Johns Hopkins Hospital Baltimore Maryland 21287 Recruiting
Dana Farber Cancer Center, Harvard University Boston Massachusetts 02215 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
NYU Langone Medical Center New York New York 10016 Recruiting
Columbia University Medical Center New York New York 10032 Recruiting
Case Comprehensive Cancer Center, Case Western Medical Reserve Cleveland Ohio 44106 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
University of Pittsburgh Pittsburgh Pennsylvania 15213 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02000089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02000089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →